These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24161533)

  • 1. Direct AT₂ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient mice.
    Kljajic ST; Widdop RE; Vinh A; Welungoda I; Bosnyak S; Jones ES; Gaspari TA
    Int J Cardiol; 2013 Nov; 169(4):281-7. PubMed ID: 24161533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S
    J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
    Tesanovic S; Vinh A; Gaspari TA; Casley D; Widdop RE
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1606-13. PubMed ID: 20448208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production.
    Shimada K; Hirano E; Kimura T; Fujita M; Kishimoto C
    Exp Biol Med (Maywood); 2012 Sep; 237(9):1039-44. PubMed ID: 22946091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice.
    Buus NH; Hansson NC; Rodriguez-Rodriguez R; Stankevicius E; Andersen MR; Simonsen U
    Eur J Pharmacol; 2011 Nov; 670(2-3):519-26. PubMed ID: 21958874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model.
    Gaspari T; Welungoda I; Widdop RE; Simpson RW; Dear AE
    Diab Vasc Dis Res; 2013 Jul; 10(4):353-60. PubMed ID: 23673376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice.
    Vinh A; Widdop RE; Drummond GR; Gaspari TA
    Cardiovasc Res; 2008 Jan; 77(1):178-87. PubMed ID: 18006471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice.
    Tiyerili V; Beiert T; Schatten H; Camara B; Jehle J; Schrickel JW; Nickenig G; Andrié RP
    Atherosclerosis; 2016 Aug; 251():430-437. PubMed ID: 27341752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma.
    Vinh A; Widdop RE; Chai SY; Gaspari TA
    Atherosclerosis; 2008 Sep; 200(1):37-44. PubMed ID: 18282573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
    Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase inhibition by piceatannol-3'-O-β-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet.
    Woo A; Shin W; Cuong TD; Min B; Lee JH; Jeon BH; Ryoo S
    Int J Mol Med; 2013 Apr; 31(4):803-10. PubMed ID: 23443634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II].
    ZHAO R; YAO YY; DENG G; JU SH; WANG ZJ; WEN S; CHEN J; JIN H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):823-8. PubMed ID: 21092653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.
    Jääskeläinen AE; Seppälä S; Kakko T; Jaakkola U; Kallio J
    Neuropeptides; 2013 Apr; 47(2):67-73. PubMed ID: 23261359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
    Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.